Richard A. Larson to United States Food and Drug Administration
This is a "connection" page, showing publications Richard A. Larson has written about United States Food and Drug Administration.
Connection Strength
0.078
-
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv. 2018 02 27; 2(4):444-453.
Score: 0.036
-
Gemtuzumab ozogamicin: time to resurrect? J Clin Oncol. 2012 Nov 10; 30(32):3921-3.
Score: 0.025
-
End points to establish the efficacy of new agents in the treatment of acute leukemia. Blood. 2007 Mar 01; 109(5):1810-6.
Score: 0.017